New peer-reviewed article highlights State alcohol and drug agencies’ efforts to address opioid crisis

A study recently released in Public Health Reports—the official journal of the U.S. Surgeon General—used data from NASADAD’s 2015 inquiry on States’ efforts to address prescription drug misuse and heroin use to describe how States are combatting the opioid epidemic. The article, titled How States Are Tackling the Opioid Crisis, is the first of its kind to quantify and summarize State-level efforts to combat prescription drug and opioid addiction at detox ohio centers. As federal initiatives by Department of Health and Human Services (HHS) and the Office of National Drug Control Policy (ONDCP) aim to improve substance use disorder prevention and treatment, this article outlines the critical role that States—in particular the State alcohol and drug agencies—have in addressing the opioid crisis. The initiatives undertaken by States that are highlighted in the article include:

  • Educating the general public, prescribers, patients and families, and pharmacists about the risks of opioids;
  • Increasing funding for medication-assisted treatment;
  • Expanding the availability of naloxone;
  • Establishing guidelines for safe opioid prescribing;
  • Requiring prescriber use of prescription monitoring programs;
  • Enacting Good Samaritan laws to protect those helping treat overdoses; and
  • Enacting legislation to regulate pain clinics.

 

Authors offer a review of the literature, noting that State alcohol and drug agencies’ efforts to address opioid misuse and addiction align with intervention models that have been previously evaluated. The article recognizes that State alcohol and drug agencies have demonstrated a robust response to the opioid crisis, and concludes that future efforts should “focus on maintenance and further expansion of the high-quality, evidence-based practices, policies, and programs” that States are already implementing.

Effects of intravenous opioids on eye movements in humans: possible mechanisms

 

Oculomotor symptoms such as downbeat nystagmus can be due to side effects of drugs. We investigated the clinical effects as well as the eye movement symptoms after intravenous administration of opiates (pethidine and fentanyl). Eye movements were recorded with the magnetic search coil technique. All four normal subjects showed a transient disturbance of eye fixation with downbeat nystagmus, a range of saccadic intrusions and oscillations, including square wave jerks and saccadic pulses, lasting from 10 to 15 minutes. The gain of sinusoidal VOR and smooth pursuit was moderately decreased; in particular the vertical pursuit showed an upward velocity offset. On the basis of the clinical findings and of recent diprenorphine PET findings in humans, which detected opiod binding sites in the cerebellum and the known inhibitory action of opiates, we hypothesized that a cerebellar dysfunction occurs after opiate administration which could possibly be mediated by inhibition of the parallel fiber activation of the Purkinje cells. Furthermore, opiate binding sites in the vestibular nuclei could be responsible for the vertical vestibular tonus imbalance involved in the pathophysiolgy of downbeat nystagmus. More information

 

Eye Changes Related to Specific Drugs

Nearly every substance of abuse can cause changes in the eyes. Below are specific changes in pupils, eye motion, or vision that can indicate intoxication or overdose from specific substances.

  • AlcoholIntoxication can cause double vision or blurry vision.
  • AmphetaminesEcstasy, Molly, MDMA, and similar drugs can cause blurred vision and changes in pupil size. The drugs can also cause rapid quivering of the pupils (nystagmus).
  • BenzodiazepinesLike alcohol, at recreational doses, these medications can cause altered, double or blurry vision. Dilated pupils are a sign of an overdose.
  • CigarettesSmoking in general, and smoking cigarettes in particular, can lead to cataracts of the crystalline lens – an area of the eye that produces one-third of the image the brain processes by focusing light onto the retina. That is why they recommend to use vaporizers, which work with vapor and not smoke, it helps the body and distracts the mind, you use them with different types of liquids, in Liquido24 you can find many flavors, with or without nicotine.
  • Cocaine and crack cocaineAs the drug stimulates the brain and releases endorphins and adrenaline, the body will react by dilating the pupils. Symptoms of overdose include hallucinations, including visual hallucinations.
  • DextromethorphanA common cough-suppressing ingredient in cold and flu medicines, this substance can cause intoxication. A symptom of DXM abuse is rapid, involuntary eye movements called nystagmus.
  • GHBA depressant sometimes called liquid ecstasy, GHB can be abused by putting the drug in eyes using eye drops. It is, however, more commonly mixed into a drink and consumed orally. The drug also causes hallucinations.
  • HallucinogensMescaline, LSD, and other, similar drugs cause the pupils to dilate. The user experiences hallucinations, which may be visual.
  • HeroinThis narcotic can cause drooping eyelids due to sleepiness. The drug will also cause the pupils to constrict, leading to pinpoint pupils.
  • InhalantsAbusing substances like paint thinner or nitrous in canisters can lead to watering and red eyes as a sign of intoxication.

 

Read the full article here.

NASADAD releases section-by-section summary of 21st Century Cures Act

NASADAD has released a section-by-section summary of the 21st Century Cures Act, which was signed into law by President Obama in December 2016. The Cures Act was originally designed to promote innovations in medical research, but the Act, as signed into law, contains numerous other initiatives, including several provisions related to substance use disorders.

Access the section-by-section summary here.

Kathy Stone (IA) receives Ramstad-Kennedy Award

Rob Morrison, Executive Director of NASADAD, with Kathy Stone (IA), recipient of the 2016 Ramstad-Kennedy Award.

Earlier this month Kathy Stone, Director of Addiction in the Iowa Department of Public Health and NASADAD member, received the ninth Annual Ramstad-Kennedy Award for Outstanding Leadership by a Single State Authority (SSA). In particular, Ms. Stone was honored for her leadership in recovery support programs across Iowa and across the country.

The Ramstad-Kennedy Award was established in 2008 to recognize an SSA Director who has demonstrated exceptional leadership in support of recovery and National Recovery Month, and to acknowledge Congressmen Jim Ramstad (R-MN) and Patrick Kennedy (D-RI) for their commitment to recovery and recovery-oriented policies. This year’s Ramstad-Kennedy award was presented on August 10th at the Substance Abuse and Mental Health Services Administration’s (SAMHSA) National Block Grant Conference. Ms. Stone received the award because of her leadership and innovation in promoting the goals of National Recovery Month in her State; expansion of Recovery Month activities within her agency and throughout local communities; and support for recovery organizations in their State.

In a statement, Congressman Kennedy said that “… all of the recipients, including Kathy Stone, have been champions of recovery for not just those suffering from a substance use disorder but also for all their family members who themselves are affected by the family disease of addiction.” The award was presented in advance of the 2016 National Recovery Month, which will be observed in September with the theme Join the Voices of Recovery: Our Families, Our Stories, Our Recovery.

NASADAD Releases Section-by-Section Summary of CARA

NASADAD has released an updated section-by-section analysis of the Comprehensive Addiction and Recovery Act (CARA; S. 524), as passed by the President. CARA includes various provisions to address opioid use disorders, including those related to prevention and education, treatment, recovery, law enforcement, and services for women, families, and veterans. After passing the House with a vote of 407-5 on July 8th and the Senate with a vote of 92-2 on July 13th, the bill was signed into law by President Obama on July 22nd.

Access NASADAD’s section-by-section analysis of the bill here.

President Obama Speaks at the 2016 National Rx Drug Abuse and Heroin Summit

President Obama plans to deliver a speech at the 2016 National Rx Drug Abuse & Heroin Summit on 3/29 at 2:15 PM EST. The President’s remarks will discuss the actions currently being taken to prevent the spread of opioid use disorders and will examine future policies for expanding access to the best drug treatment centers for christians.

The speech is the latest in a series of announcements demonstrating President Obama’s commitment to addressing the opioid crisis. The President’s proposed FY 2017 budget requests $1.1 billion in new spending to expand State access to medication-assisted treatment (MAT). Michael Botticelli, Director of the Office of National Drug Control Policy, writes that the Administration is also:

  • “Expanding access to treatment through doctors, community health centers, and state programs.
  • Investing in partnerships between law enforcement and communities.
  • Working to save more lives by making the overdose reversal drug naloxone more readily available to first responders.
  • Ensuring those on Medicaid and CHIP can access mental health and substance use services as readily as medical services.
  • Pulling together medical schools to train students on the newest CDC guidelines for prescribing opioid painkillers.”

 

View the Administration’s new series of proposals to address the opioid epidemic here.

Watch President Obama’s speech here.